Literature DB >> 16919252

The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation.

Yen-Hung Lin1, Yi-Lwun Ho, Tzung-Dau Wang, Chung-Pin Liu, Hsien-Li Kao, Chia-Lun Chao, Kuo-Liong Chien, Chi-Sheng Hung, Vin-Cent Wu, I-Jung Tsai, Ruoh-Fang Yen, Yu-Chien Shiau, Wen-Jone Chen.   

Abstract

OBJECTIVES: The association of cardiac fibrosis and coronary artery disease (CAD) in patients without infarction or hibernation is unclear. We investigated the relationship between serum concentrations of procollagen propeptides and severity of CAD in such patients. DESIGN AND METHODS: Forty-six patients (32 men; mean age 64 years) with chest pain were enrolled. All patients received stress thallium-201 single photon emission computed tomography (SPECT) and analysis of the serum levels of the amino-terminal propeptide of type I and III procollagen (PINP and PIIINP).
RESULTS: In patients with thallium-201 perfusion defects, the number of diseased vessels was associated significantly with PIIINP (p=0.024) rather than PINP (p=0.613). Follow-up serum PINP and PIIINP levels after coronary intervention (mean 84 days) revealed no significant decrease.
CONCLUSIONS: Serum PIIINP level is significantly associated with the severity of CAD in patients without myocardial infarction or hibernation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919252     DOI: 10.1016/j.clinbiochem.2006.05.017

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death.

Authors:  Yen-Hung Lin; Chen Lin; Men-Tzung Lo; Hung-Ju Lin; Yen-Wen Wu; Ron-Bin Hsu; Chia-Lun Chao; Hsiu-Ching Hsu; Pa-Chun Wang; Vin-Cent Wu; Shoei-Shen Wang; Chi-Ming Lee; Kuo-Liong Chien; Yi-Lwun Ho; Ming-Fong Chen; Chung-Kang Peng
Journal:  Clin Chem Lab Med       Date:  2010-09-17       Impact factor: 3.694

2.  Use of biomarkers of collagen types I and III fibrosis metabolism to detect cardiovascular and renal disease in chimpanzees (Pan troglodytes).

Authors:  John J Ely; Micah A Bishop; Michael L Lammey; Meg M Sleeper; Jörg M Steiner; D Rick Lee
Journal:  Comp Med       Date:  2010-04       Impact factor: 0.982

3.  Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.

Authors:  Balsam El Ghoul; Tarek Squalli; Aude Servais; Caroline Elie; Vannary Meas-Yedid; Christine Trivint; Jill Vanmassenhove; Jean-Pierre Grünfeld; Jean-Christophe Olivo-Marin; Eric Thervet; Laure-Hélène Noël; Dominique Prié; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

4.  The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.

Authors:  Mette J Nielsen; Anders F Nedergaard; Shu Sun; Sanne S Veidal; Lise Larsen; Qinlong Zheng; Charlotte Suetta; Kim Henriksen; Claus Christiansen; Morten A Karsdal; Diana J Leeming
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

5.  Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease.

Authors:  Dong Fan; Abhijit Takawale; Jiwon Lee; Zamaneh Kassiri
Journal:  Fibrogenesis Tissue Repair       Date:  2012-09-03

6.  Suitable bone markers assessing bone status in patients with both coronary artery disease and diabetes.

Authors:  Zhila Maghbooli; Solaleh Emamgholipour; Arash Hossein-Nezhad; Mahmood Shirzad; Sattar Gorgani Firuzjaee
Journal:  J Diabetes Metab Disord       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.